Navitas Life Sciences will soon be adding to our portfolio of industry leading networks with the launch of pvindia; a network for Heads of Safety of Indian life sciences companies with pharma, consumer, generics, or mixed portfolios.

January 25, 2016, Princeton, New Jersey: Navitas Life Sciences will soon be adding to our portfolio of industry leading networks with the launch of pvindia; a network for Heads of Safety of Indian life sciences companies with pharma, consumer, generics, or mixed portfolios.

pvindia will leverage the approach, format and experience gained from successfully running pvnetworks over the past 14 years in Europe and the USA. This is a unique opportunity to be part of the industry leading global network for pharmacovigilance professionals.

pvindia will provide a neutral platform for pharmacovigilance leaders facing similar challenges to network, debate, compare performance, and share ideas on how to tackle the latest hot issues.

The inaugural pvindia will take place on Thursday, March 3rd at Taj lands’ End, Band Stand, Bandra (West), in Mumbai. For further information please click here to register your interest in participating, please contact a member of our networks team at This email address is being protected from spambots. You need JavaScript enabled to view it.

pvindia

 

Latest News

01
Dec2017

Navitas brings End – to – End R&D Solutions to the Generic Drug Industry

Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver “first...